Berkeley, CA - October 24, 2006 - Robert Ward, founder and CEO of the Polymer Technology Group, Inc. (PTG), will be presented with the 2006 Excellence in Surface Science Award by the Surfaces in Biomaterials Foundation. This prestigious award formally recognizes outstanding researchers for significant contributions to the field of surface science. The award, which will be presented at the upcoming BioInterface 2006 Conference in San Mateo, California on Wednesday, December 6th, 2006, is a major acknowledgement of Ward's lifetime of contributions to the field of surface sciences.
This award celebrates Robert Ward's distinguished career in the development of biomedical polyurethane for cardiovascular and other applications; a career which spans the early days of the intraaortic balloon pumps and ventricular assist devices, to modern day spinal implants. Together with his colleagues at the Polymer Technology Group Inc., he has made a significant impact on the field of medical devices, as exemplified by the introduction of BioSpan®, Bionate®, and Elasthane™ as high quality, well defined replacement biomaterials at a crucial time when legal pressures lead to the complete absence of these materials from the marketplace. The contributions continue today with the development of the highly novel Surface Modifying End Group technology, allowing device manufacturers to specify particular surface interfacial chemistries, while retaining the generally desirable bulk properties of polyurethanes. These accomplishments and many other innovations from Robert Ward and the Polymer Technology Group continue to advance the science and engineering of biomaterial interface.
The Polymer Technology Group was founded in 1989 by Robert Ward, who is a recognized pioneer in the field of biomaterials and the company's CEO. PTG specializes in the research, development, design, scale-up, and manufacture of new polymers, medical devices, and components. PTG's commercial product portfolio also includes two of the world's most extensively tested biomaterials in clinical use today, BioSpan® segmented polyurethane and Bionate® polycarbonate urethane. In addition, PTG offers custom-fabricated components from our patented PurSil™ silicone polyether urethane and CarboSil® silicone polycarbonate urethane. PTG's three facilities totaling 50,000 square-foot house the equipment and expertise to support production-scale polymer synthesis through contract medical device manufacturing.
Rahul Tembhekar, Marketing Manager
The Polymer Technology Group, Inc.
2810 7th Street
Berkeley, California 94710